BOLT vs ED · rev $7.7M vs P/E 18, rev $15.26B
Bolt Biotherapeutics (BOLT) versus Consolidated Edison Inc (ED) — a side-by-side from cached financials, not a winner call.
Bolt Biotherapeutics (BOLT) is a biotechnology company listed on US.
Consolidated Edison Inc (ED) is a utilities - regulated electric company listed on US.
Latest reported BOLT revenue for 2024-12-31 was $7.7M. Net income was -$63.1M. Revenue was down 2.4% from 2023-12-31 to 2024-12-31. BOLT currently screens at market cap $11.3M.
Latest reported ED revenue for 2024-12-31 was $15.26B. Net income was $1.82B. Revenue was up 4.0% from 2023-12-31 to 2024-12-31. ED currently screens at market cap $36.02B and trailing P/E 18.3.
BOLT currently screens at market cap $11.3M. ED currently screens at market cap $36.02B and trailing P/E 18.3.
Not investment advice. Open the BOLT and ED stock pages for the full models.
Not investment advice.